ENTITY
stringlengths 8
8
| DEFINITION
stringlengths 3
8.47k
⌀ | ALIASES
stringlengths 2
13.6k
⌀ | NAME
stringlengths 2
1.98k
|
---|---|---|---|
C0007422 | Agents that are used to stimulate evacuation of the bowels. | purgative|cathartics|Cathartic (substance)|Cathartic, NOS|Purgative|cathartic|Bowel Evacuants|Purgative, NOS|Evacuants, Bowel|Cathartics|Purgatives|Cathartic|purgatives | Cathartics |
C0085983 | A cell line derived from cultured tumor cells. | tumor cell line|Cell Lines, Tumor|Line, Tumor Cell|Tumor Cell Lines|Tumor Cell Line|tumor cell lines|Lines, Tumor Cell | Cell Line, Tumor |
C0029045 | Female germ cells derived from OOGONIA and termed OOCYTES when they enter MEIOSIS. The primary oocytes begin meiosis but are arrested at the diplotene state until OVULATION at PUBERTY to give rise to haploid secondary oocytes or ova (OVUM). | oocytes|Oocyte|oocyte|Oocytes|Ovocyte, NOS|ovocyte|Ovocyte|Ovocytes|oocyte (cell)|Oocyte (cell)|cells oocytes|Oocyte, NOS | Oocytes |
C0002938 | The chromosomal constitution of cells which deviate from the normal by the addition or subtraction of CHROMOSOMES, chromosome pairs, or chromosome fragments. In a normally diploid cell (DIPLOIDY) the loss of a chromosome pair is termed nullisomy (symbol: 2N-2), the loss of a single chromosome is MONOSOMY (symbol: 2N-1), the addition of a chromosome pair is tetrasomy (symbol: 2N+2), the addition of a single chromosome is TRISOMY (symbol: 2N+1). | aneuploidy|aneuploidies|Aneuploid|Alteration of chromosome number|Alteration of chromosome number, NOS|Aneuploids|aneuploid|Aneuploidy, NOS|Numerical Chromosomal Alterations|Aneuploidies|Aneuploidy (morphologic abnormality)|Aneuploidy | Aneuploidy |
C0017471 | The reproductive cells in multicellular organisms at various stages during GAMETOGENESIS. | cells germ|Meiotic cell|Germ-Line Cell|Sex Cell|initial cell|cells sex|sexual cell|Meiotic cell, NOS|Germ-Line Cells|germ cell|sex cell|Germ Cells|Cell, Germ-Line|Germ cell (cell structure)|Cells, Germ-Line|cell sex|Haploid germ cell|Gametes|Sexual Cell|Germinal cell|Reproductive Cells|Germ cells|cell germ|Germ Cell|Germ cell|Germ Line Cells|Cell, Germ|reproductive cells|germ cells|Cells, Germ|Gamete|Haploid nucleated cell|reproductive cell | Germ Cells |
C0028303 | The failure of homologous CHROMOSOMES or CHROMATIDS to segregate during MITOSIS or MEIOSIS with the result that one daughter cell has both of a pair of parental chromosomes or chromatids and the other has none. | Genetic Nondisjunction|Genetic Nondisjunctions|Genetic Non-Disjunction|Genetic non disjunction (finding)|Non-Disjunction, Genetic|Non Disjunction, Genetic|Genetic Non Disjunction|Genetic non disjunction|Nondisjunctions, Genetic|Non-Disjunctions, Genetic|Nondisjunction, Genetic|nondisjunction|Genetic Non-Disjunctions | Nondisjunction, Genetic |
C0025362 | A developmental disorder characterized by less than average intelligence and significant limitations in adaptive behavior with onset before the age of 18. | mental retardations|Mental retardation, NOS|MENTAL RETARDATION|mental retardation diagnosis|Mental Retardation|Mental-retardation|Mental retardation|mr|mental retardation|RETARDATION MENTAL | Mental Retardation |
C0796346 | Short repeats of nucleotide sequences present throughout the genome which exhibit variations within a population. | null | Polymorphic Microsatellite Marker |
C1519758 | Interchanges of genetic material among different chromosomes following the breaking off of pieces of chromosomes such that the total chromosome composition does not contain all of the genetic material. | Unbalanced Chromosomal Alteration/Rearrangement|Unbalanced Chromosomal Rearrangement|Unbalanced Chromosomal Alteration | Unbalanced Translocation |
C0153594 | A primary or metastatic malignant neoplasm that affects the testis. Representative examples include seminoma, embryonal carcinoma, sarcoma, leukemia, and lymphoma. | Malignant tumor of testis|testicular cancers|testis cancer|cancer testicular|Cancers, Testicular|Malignant neoplasm of testis|testicle cancer|Cancers, Testis|Testis Cancer|Testis Cancers|Malignant tumor of testis (disorder)|Testicular Cancer|Cancer of testis|Malignant Tumor of the Testis|Malignant Tumor of Testis|Malignant Testicular Tumor|Malignant tumour of testis|Malignant Neoplasm of Testis|Cancer, Testis|cancer testicles|Testis--Cancer|TESTIS NEOPLASM MALIGNANT|Cancer of Testis|cancer of the testis|testicular cancer|Malignant Neoplasm of the Testis|cancer testis|Testicular Cancers|Cancer of the Testes|Malignant Testicular Neoplasm|Malignant neoplasm of testis, NOS|Testicular cancer|Cancer, Testicular|Cancer of the Testis|cancer testicle | Malignant neoplasm of testis |
C0796121 | A rare genetic intellectual disability syndrome with characteristics of macrocephaly, hypotonia, dysmorphic facial features (wide forehead, ptosis, downslanting palpebral fissures, enlarged and calcified external ears, large jaw), sparse body hair and tall stature. Hearing loss, insulin-resistant diabetes, and progressive distal muscle wasting (leading to joint contractures) have also been reported in adulthood. Rare manifestations include hypothyroidism, cerebral calcification, ataxia and peripheral neuropathy. There is evidence this disease is caused by heterozygous mutation in the ZBTB20 gene on chromosome 3q13. | Intellectual disability, cataract, calcified pinna, myopathy syndrome|PRIMS|Primrose syndrome|OSSIFIED EAR CARTILAGES WITH MENTAL DEFICIENCY, MUSCLE WASTING, AND BONY CHANGES|Intellectual disability, cataract, calcified pinna, myopathy syndrome (disorder)|PRIMROSE SYNDROME | Primrose syndrome |
C0022417 | Also known as articulations, these are points of connection between the ends of certain separate bones, or where the borders of other bones are juxtaposed. | joint|joints types|JOINT|Joints set|Joint, NOS|Articular|joint types|Articulation|articulation|Set of joints|joint structure|Joint structure|anatomy joints|joints structures|anatomy joint|jointing|Junctura|joints anatomy|Joints|Joint types|Joint structure (body structure)|joints|joints type|Joint|Joints, NOS|articulations | Joints |
C0227997 | The testis on the right side of the body. | right testicle|Right Testis|Right testis|Structure of right testis|right testis|Right testicle|Structure of right testis (body structure) | Structure of right testis |
C0013453 | The outer part of the hearing system of the body. It includes the shell-like EAR AURICLE which collects sound, and the EXTERNAL EAR CANAL, the TYMPANIC MEMBRANE, and the EXTERNAL EAR CARTILAGES. | external ear|External ear structure|outer ear|Ear, Outer|Outer Ears|EAR, OUTER|ears outer|Ears, Outer|Pinna|PINNA|Ear, External|Outer Ear|Ears, External|Outer ear|External Ears|External ear|Auricular region of head|External Ear|ear outer|Auricle|Regio auricularis (capitis)|ear external|External ear structure (body structure)|External ear, NOS|external ears|EXTERNAL EAR|Auris externa|Auricular region | External Ear |
C0010417 | A developmental defect in which a TESTIS or both TESTES failed to descend from high in the ABDOMEN to the bottom of the SCROTUM. Testicular descent is essential to normal SPERMATOGENESIS which requires temperature lower than the BODY TEMPERATURE. Cryptorchidism can be subclassified by the location of the maldescended testis. | undescended testes|UNDESCENDED TESTES|testes undescend|Cryptorchism|Undescended testicle|maldescent of testis|Undescended Testis|cryptorchidism|Undescended testes|undescended testicle|undescended testicles|Maldescent of testis|Cryptorchidism, unilateral or bilateral|Imperfectly descended testis|CRYPTORCHISM|cryptorchism|Cryptorchidism|Undescended testis|UNDESCENDED TESTIS|UDT - Undescended testes|testicles undescended|CRYPTORCHIDISM, UNILATERAL OR BILATERAL|Undescended Testicle|undescend testicle|Testes, Undescended|Cryptorchid|maldescended testis|Cryptorchidism (unilateral or bilateral)|Cryptorchidism, Unilateral Or Bilateral|Retained testicle|Undescended testicles|undescended testis|Testis, Undescended|testicle undescended|IDT - Imperfectly descended testis|UNDESCENDED TESTICLE|Undescended Testes|Undescended testicle (disorder)|CRYPTORCHIDISM | Cryptorchidism |
C0037284 | A localized pathological or traumatic structural change, damage, deformity, or discontinuity of skin. | lesions skin|disorders lesions skin|skin lesion|Skin Lesion|disorder lesions skin|SKIN LESION|Skin lesion, NOS|lesion skin|Skin lesion (disorder)|Skin lesions | Skin lesion |
C1279153 | null | Entire cheek|Entire buccal region of face|Entire cheek (body structure) | Entire cheek |
C0931557 | null | Palm of right hand|Structure of palm of right hand (body structure)|Right palm | Structure of palm of right hand |
C1279999 | null | Entire left foot (body structure)|Entire left foot | Entire left foot |
C0205100 | On or near an edge or constituting an outer boundary; the outer area. | Peripheral (qualifier value)|PERIPHERAL|Peripheral|peripheral | Peripheral |
C0018055 | A type of defective gonadal development in patients with a wide spectrum of chromosomal mosaic variants. Their karyotypes are of partial sex chromosome monosomy resulting from an absence or an abnormal second sex chromosome (X or Y). Karyotypes include 45,X/46,XX; 45,X/46,XX/47,XXX; 46,XXp-; 45,X/46,XY; 45,X/47,XYY; 46,XYpi; etc. The spectrum of phenotypes may range from phenotypic female to phenotypic male including variations in gonads and internal and external genitalia, depending on the ratio in each gonad of 45,X primordial germ cells to those with normal 46,XX or 46,XY constitution. | 45,X/46,XY Gonadal Dysgenesis|Mixed Gonadal Dysgenesis|Mixed gonadal dysgenesis|45, X/46, XY mosaicism|Mixed gonadal dysgenesis syndrome|Mixed gonadal dysgenesis (disorder)|45,X/46,XY Mixed Gonadal Dysgenesis|45,X/46,XY Disorder of Sex Development|Mosaicism 45, X; 46, XY | Gonadal Dysgenesis, Mixed |
C0041408 | A syndrome of defective gonadal development in phenotypic females associated with the karyotype 45,X (or 45,XO). Patients generally are of short stature with undifferentiated GONADS (streak gonads), SEXUAL INFANTILISM, HYPOGONADISM, webbing of the neck, cubitus valgus, elevated GONADOTROPINS, decreased ESTRADIOL level in blood, and CONGENITAL HEART DEFECTS. NOONAN SYNDROME (also called Pseudo-Turner Syndrome and Male Turner Syndrome) resembles this disorder; however, it occurs in males and females with a normal karyotype and is inherited as an autosomal dominant. | xo syndrome|monosomy X syndrome|Ullrich-Turner syndrome|TS - Turner's syndrome|turner's syndrome|gonadal dysgenesis|Turner syndrome (disorder)|45,X Gonadal Dysgenesis|Turner Syndrome|DWARFISM, OVARIAN|Syndrome, Ullrich-Turner|gonadal dysgenesis syndrome|Bonnevie-Ullrich Syndrome|bonnevie-ullrich syndrome|Monosomy X|Pterygolymphangiectasia syndrome|45X Syndrome|Turner's syndrome|Turner Syndrome (XO Syndrome)|TURNER-VARNY SYNDROME|Ullrich Turner Syndrome|Turner's Syndrome|TURNER SYNDROME|XO SYNDROME|Turners Syndrome|Gonadal Dysgenesis|Turner syndrome|ULLRICH-TURNER SYNDROME|XO Syndrome|Ullrich-Turner Syndrome|45, X syndrome|XO syndrome|Turner syndrome, NOS | Turner Syndrome |
C0333710 | An abnormal chromosome with two centromeres as opposed to the normal one centromere. | Dicentric chromosome|dic|Dicentric|Dicentric chromosome (morphologic abnormality)|Dicentric Chromosome | Dicentric chromosome |
C0182400 | A device designed to reach into a location for manipulating or sensing. | Probe, device (physical object)|Probe|Probe, NOS|PROBE|probe|Probe, device|Probe Device|probes | Probes |
C1522384 | The totality of characteristics of reproductive structure, functions, PHENOTYPE, and GENOTYPE, differentiating the MALE from the FEMALE organism. | Gender|Sex of individual, NOS|SEX|Sex, NOS|Sex|Sex structure (body structure)|sex|Sex structure | sex |
C0740404 | null | defects limbs|limb defect|defect limb | limb defects |
C0742342 | null | null | chest syndrome |
C0015576 | A social group consisting of parents or parent substitutes and children. | familial|families|Family Group|Families|Familial|family|Family (social concept)|Family|Family, NOS | Family |
C0006141 | In humans, one of the paired regions in the anterior portion of the THORAX. The breasts consist of the MAMMARY GLANDS, the SKIN, the MUSCLES, the ADIPOSE TISSUE, and the CONNECTIVE TISSUES. | Breasts|Mamma|Breast|BREAST|Mammary|BREASTS|mamma|Breast, NOS|Mammary region|breast|Mammary part of chest|Breast anatomy|Breast structure (body structure)|mammary|breast structure|breasts|Breast structure | Breast |
C0221984 | null | Structure of hair of axilla|Axillary hairs set|Axillary hairs|Structure of hair of axilla (body structure)|Hair of axilla|Axillary hair|Hirci|Set of axillary hairs | Structure of hair of axilla |
C0006926 | Cyclic amide of caproic acid used in manufacture of synthetic fibers of the polyamide type. Can cause local irritation. | Lactam, Aminocaproic|Caprolactam|Aminocaproic Lactam|2H-Azepin-2-one, hexahydro-|Hexahydro 2H Azepin 2 One|Caprolactam (substance)|Hexahydro-2H-Azepin-2-One | Caprolactam |
C1516821 | The rudimentary heart found in the human embryo that begins development during the third week of gestation, and which is formed by paired endocardial heart tubes derived from splanchnic mesenchyme, which subsequently fuse to form the primitive heart. | Embryonic Heart | Embryonic heart |
C0752059 | null | Region, Septal | Septal Region |
C1140618 | The region of the upper limb in animals, extending from the deltoid region to the HAND, and including the ARM; AXILLA; and SHOULDER. | Upper Limb|Extremities, Upper|upper limb|Upper Extremities|Upper Extremity|Forelimb|Upper extremity, NOS|Upper extremity|Membrum superius|Upper limb structure|FORELIMB|Upper limb structure (body structure)|Arm|LIMB, UPPER|upper limbs|upper extremities|UPPER EXTREMITIES|upper extremity|Extremity, Upper|Forelimb, NOS|Fore limb|Limbs, Upper|arm|Superior member|Upper Limbs|Upper limb|Upper limb, NOS|Limb, Upper | Upper Extremity |
C0015385 | The farthest or outermost projections of the body, such as the HAND and FOOT. | Limb, NOS|limb|LIMB|extremities|limbs|Extremities (Anatomy)|Extremity, NOS|arms and legs|Limb structure (body structure)|Limbs|Extremities|Limb|Extremity|Limb structure|extremity | Limb structure |
C0920502 | Tissue that is formed during the embryonic stage of life of an organism. | Embryonic Tissue|Embryonic tissue|embryo tissue|Germ layer | Embryonic tissue |
C0337871 | null | Inca|Inca (ethnic group)|inca|incas | Inca (ethnic group) |
C0337884 | null | Quechua (ethnic group)|Quechua | Quechua (ethnic group) |
C0039082 | A characteristic symptom complex. | syndrome|Symptom Cluster|Syndromes|Cluster, Symptom|Clusters, Symptom|Syndrome, NOS|Symptom Clusters|Syndrome|syndromes | Syndrome |
C0027342 | The thin, horny plates that cover the dorsal surfaces of the distal phalanges of the fingers and toes of primates. | Unguis|Nail plate structure|unguis|nail structure|Nail Plate|NAILS|Nail|nail plate|Nail, NOS|nail|Nail plate structure (body structure)|Nail Apparatus|nail plates|Nails|NAIL|nails|Nail plate | Nail plate |
C0008377 | The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. | (3beta)-Cholest-5-en-3-ol|Cholest-5-en-3beta-ol|(-)-Cholesterol|(3β,14β,17α)-cholest-5-en-3-ol|5-cholesten-3B-ol|Cholesterol|cholesterol|Cholesterol (substance)|Cholest-5-en-3-ol (3beta)-|CHOLESTEROL | cholesterol |
C0023779 | A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and fatty acids. (Grant & Hackh's Chemical Dictionary, 5th ed) | Lipids|lipids|Lipid|Lipid, NOS|lipid|Lipid (substance) | Lipids |
C0010362 | Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. | Cross Sectional Survey|Surveys, Disease Frequency|Cross-Sectional Surveys|CROSS SECTIONAL|Cross-Sectional Study|Cross Sectional Analyses|Cross Sectional Analysis|Disease Frequency Surveys|Study, Cross-Sectional|Cross-Sectional Analysis|Studies, Cross-Sectional|Cross Sectional Studies|Surveys, Cross-Sectional|Survey, Disease Frequency|Cross-Sectional Survey|Analysis, Cross-Sectional|Cross-Sectional Analyses|Analyses, Cross Sectional|Analysis, Cross Sectional|cross sectional study|Survey, Cross-Sectional|Analyses, Cross-Sectional|cross-sectional study|Disease Frequency Survey|cross-sectional studies | Cross-Sectional Studies |
C0018674 | Traumatic injuries involving the cranium and intracranial structures (i.e., BRAIN; CRANIAL NERVES; MENINGES; and other structures). Injuries may be classified by whether or not the skull is penetrated (i.e., penetrating vs. nonpenetrating) or whether there is an associated hemorrhage. | Craniocerebral Injury|HEAD INJURY|Craniocerebral Injuries|Craniocerebral Traumas|craniocerebral trauma|Injury, Craniocerebral|head trauma|Injuries, Head|Traumas, Head|Traumas, Craniocerebral|Trauma, Head|Injury of head|Head injury, NOS|Head injury|HEAD TRAUMA|Injury of head (disorder)|Injury of Head|Head injury, unspecified|Trauma, Craniocerebral|Injury of head, NOS|head injury|head traumas|Head Injury|injuries to the head|Injuries, Craniocerebral|HI - Head injury|Head trauma|Injury of head region|Head Trauma|Head Injuries|craniocerebral injury|Injury, Head|head injuries|Head Traumas | Craniocerebral Trauma |
C0010754 | A widely occurring subclass of c type cytochromes which function as electron carriers in the electron transport chain in photosynthetic and denitrifying BACTERIA. | Cytochrome c'|Ferricytochrome c'|Cytochromes c Prime|Cytochromes c' | Cytochromes c' |
C0436307 | Treatment that combines chemotherapy with radiation therapy. Chemoradiation can be concurrent or sequential. | Radiochemotherapy|CRT|Chemoradiation|radiochemotherapy (non-specific)|CRTx|RT-CT|chemoradiotherapy|RCTx|Chemoradiotherapy|chemoradiation|radiochemotherapy|Chemoradiotherapies|Radiochemotherapies | Chemoradiotherapy |
C0026845 | Contractile tissue that produces movement in animals. | Muscle tissue (body structure)|Muscle Tissues|muscle tissue|Muscle tissue|Muscle Tissue|MUSCLE TISSUE|muscle|musculus|muscles|Muscle|Muscles|Tissue, Muscle|Tissues, Muscle|muscle (tissue) | Muscle Tissue |
C0015264 | Physical or mental energy; hard work. | exertions|exerted|effort|Exerted|exertion|Effort|Exertion, function (observable entity)|physical hard work|exerts|Exertion, function|exerting|Exertion, NOS|exert | Exertion |
C0030685 | The administrative process of discharging the patient, alive or dead, from hospitals or other health facilities. | Patient Discharges|PATIENT DISCHARGES|Discharged|patient discharge|Discharge, Patient|discharge|Patient discharge|Discharges, Patient|Discharge|Discharge procedure|Patient discharge (procedure)|Discharge from Healthcare Facility|Patient Discharge|Release|Patient discharge, NOS | Patient Discharge |
C0048297 | null | 4-hydroxynonenal|4-HNE cpd|4 hydroxynonenal|4-hydroxynonen-2-al|4-hydroxy-2,3-nonenal | 4-hydroxy-2-nonenal |
C0030946 | A subclass of PEPTIDE HYDROLASES that catalyze the internal cleavage of PEPTIDES or PROTEINS. | Proteinase|Peptide Peptidohydrolases|Endopeptidase|peptide peptidohydrolases|proteases|proteinases|endopeptidase|protease|Endopeptidase (substance)|Endopeptidases|proteinase|endopeptidases | Endopeptidases |
C0018787 | The hollow, muscular organ that maintains the circulation of the blood. | Cardio-|Cardiac|cardiac|Cor|heart structure|cardiac structure|HEART|Heart structure|cardi(o)-|coronary|Heart|heart|Cardiac structure|Heart structure (body structure)|Hearts|Heart, NOS | Heart |
C0023884 | A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. | Hepatic Body System|Liver structure (body structure)|Gastrointestinal Tract, Liver|Organ System, Hepatic|Hepatic Organ System|Hepar|LIVER|Liver, NOS|liver|Liver|Livers|livers|Body System, Hepatic|Liver structure|liver structure | Liver |
C0208355 | A large multisubunit complex that plays an important role in the degradation of most of the cytosolic and nuclear proteins in eukaryotic cells. It contains a 700-kDa catalytic sub-complex and two 700-kDa regulatory sub-complexes. The complex digests ubiquitinated proteins and protein activated via ornithine decarboxylase antizyme. | 20S Core Proteasome|Multicatalytic endopeptidase complex|Endopeptidase Complex, Multicatalytic|Multicatalytic Endopeptidase Complex|Complex, Multicatalytic Endopeptidase|Proteasome, 20S|20S Proteasome|Proteasome Endopeptidase Complex|Multicatalytic endopeptidase complex (substance)|Prosome|Endopeptidase Complex, Proteasome|Proteasome|proteasome|Multicatalytic proteinase (complex)|20S Catalytic Proteasome|Macropain|Multicatalytic Proteinase|prosome|Proteosome|20S Proteosome|Macroxyproteinase|Proteinase, Multicatalytic|Complex, Proteasome Endopeptidase|proteasomes | multicatalytic endopeptidase complex |
C0086132 | null | Depressive symptoms|Emotional Depression|emotional depression|Depression, Emotional|depressive symptoms|Depressive Symptom|symptoms of depression|depression symptom|Symptoms of depression|depressions symptoms|symptoms depression|Depressions, Emotional|Symptoms of depression (finding)|depressive symptom|depression symptoms|Symptoms, Depressive|Symptom, Depressive|Emotional Depressions | Depressive Symptoms |
C0596170 | A disorder associated with three or more of the following: eating until feeling uncomfortably full; eating large amounts of food when not physically hungry; eating much more rapidly than normal; eating alone due to embarrassment; feeling of disgust, DEPRESSION, or guilt after overeating. Criteria includes occurrence on average, at least 2 days a week for 6 months. The binge eating is not associated with the regular use of inappropriate compensatory behavior (i.e. purging, excessive exercise, etc.) and does not co-occur exclusively with BULIMIA NERVOSA or ANOREXIA NERVOSA. (From DSM-IV, 1994) | Binging|Binge Eating|Binge overeating|bing|Episodes of overeating|Disorder, Binge-Eating|Binge-Eating Disorders|binging|binge|Binge Eating Disorder|binge disorders eating|binge eating disorder|binge disorder eating|Binges|Disorders, Binge-Eating|Binging (finding)|Binge eating|binge eating|bingeing|Binge eating disorder (disorder)|Binge-Eating Disorder|Bouts of overeating|Bingeing|Binge eating disorder|binge-eating disorder | Binge eating disorder |
C0424290 | Excessive or pathological tendency to save and collect possessions. [] | Collectionism|Compulsive hoarding (finding)|Compulsive hoarding|compulsive hoarding | Compulsive hoarding |
C0079189 | Non-antibody proteins secreted by inflammatory leukocytes and some non-leukocytic cells, that act as intercellular mediators. They differ from classical hormones in that they are produced by a number of tissue or cell types rather than by specialized glands. They generally act locally in a paracrine or autocrine rather than endocrine manner. | cytokine|Cytokine (substance)|cytokines|Cytokine-containing product|Cytokines|Cytokine, NOS|Product containing cytokine (product)|Cytokine | cytokine |
C0040018 | An enzyme formed from PROTHROMBIN that converts FIBRINOGEN to FIBRIN. | fibrinogenase|Thrombin preparation|Product containing thrombin (medicinal product)|Thrombin|Thrombin (substance)|Thrombin-containing product|Fibrinogenase|thrombin|Thrombase|THROMBIN|thrombase | thrombin |
C0040018 | An enzyme formed from PROTHROMBIN that converts FIBRINOGEN to FIBRIN. | fibrinogenase|Thrombin preparation|Product containing thrombin (medicinal product)|Thrombin|Thrombin (substance)|Thrombin-containing product|Fibrinogenase|thrombin|Thrombase|THROMBIN|thrombase | thrombin |
C1177422 | null | benzocaine 20 % / triclosan 0.13 % Topical Spray|BENZOCAINE 200 mg in 1 mL / TRICLOSAN 1.3 mg in 1 mL TOPICAL SPRAY [First Degree Burn]|BENZOCAINE 20 g in 100 g / TRICLOSAN 130 mg in 100 g TOPICAL AEROSOL, SPRAY [Good Neighbor Pharmacy First Aid]|BENZOCAINE 17 g in 85 g / TRICLOSAN 0.11 g in 85 g TOPICAL AEROSOL, SPRAY [Benzocaine and Triclosan] | Benzocaine 200 MG/ML / Triclosan 1.3 MG/ML Topical Spray |
C1177422 | null | benzocaine 20 % / triclosan 0.13 % Topical Spray|BENZOCAINE 200 mg in 1 mL / TRICLOSAN 1.3 mg in 1 mL TOPICAL SPRAY [First Degree Burn]|BENZOCAINE 20 g in 100 g / TRICLOSAN 130 mg in 100 g TOPICAL AEROSOL, SPRAY [Good Neighbor Pharmacy First Aid]|BENZOCAINE 17 g in 85 g / TRICLOSAN 0.11 g in 85 g TOPICAL AEROSOL, SPRAY [Benzocaine and Triclosan] | Benzocaine 200 MG/ML / Triclosan 1.3 MG/ML Topical Spray |
C0600388 | A mitogen-activated protein kinase subfamily that is widely expressed and plays a role in regulation of MEIOSIS; MITOSIS; and post mitotic functions in differentiated cells. The extracellular signal regulated MAP kinases are regulated by a broad variety of CELL SURFACE RECEPTORS and can be activated by certain CARCINOGENS. | MAP Kinases, Extracellular Signal Regulated|MAP Kinases, Extracellular Signal-Regulated|Extracellular Signal-Regulated MAP Kinases|extracellular signal related kinase|MAP/ERK Kinase|ERK MAP Kinases|Threonine/Tyrosine Protein Kinase|extracellular signal regulated map kinase|Extracellular Signal-Regulated Kinases|Extracellular Signal Regulated MAP Kinases|EC 2.7.12|Extracellular Signal Regulated Kinases|Kinases, Extracellular Signal-Regulated | Extracellular Signal Regulated Kinases |
C0006104 | The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. | brains|cerebral|brain|Brain, NOS|Nervous System, Brain|Encephalon|Brain|Brain structure (body structure)|Cerebral|brain structure|Brain structure|BRAIN|encephalon | Brain |
C0033954 | An intermediate in the biosynthesis of cerebrosides. It is formed by reaction of sphingosine with UDP-galactose and then itself reacts with fatty acid-Coenzyme A to form the cerebroside. | Psychosine|Galactoside, Sphingosine|Galactosylsphingosine|beta-D-Galactopyranoside, 2-amino-3-hydroxy-4-octadecenyl, (R-(R*,S*-(E)))-|Sphingosine Galactoside | Psychosine |
C0023521 | An autosomal recessive metabolic disorder caused by a deficiency of GALACTOSYLCERAMIDASE leading to intralysosomal accumulation of galactolipids such as GALACTOSYLCERAMIDES and PSYCHOSINE. It is characterized by demyelination associated with large multinucleated globoid cells, predominantly involving the white matter of the central nervous system. The loss of MYELIN disrupts normal conduction of nerve impulses. | Galactosylceramide beta Galactosidase Deficiency Disease|Galactosylcerebrosidase Deficiency|Globoid Cell Leukoencephalopathies|Galactocerebrosidase Deficiency|Leukodystrophy, Globoid Cell|Leukodystrophies, Globoid Cell|Galactosylceramide beta-Galactosidase Deficiency|diseases krabbe|Krabbes Leukodystrophy|Diseases, Galactosylceramidase Deficiency|globoid leukodystrophy|Deficiency Disease, Galactosylceramidase|GLOBOID CELL LEUKODYSTROPHY|Diffuse Globoid Body Sclerosis|beta-Galactosidase Deficiencies, Galactosylceramide|Krabbe Disease|Psychosine Lipidosis|krabbe leukodystrophy|Leukodystrophy, Globoid|GLD|Galactocerebrosidase Deficiencies|Galactosylceramide Lipidosis|GALACTOCEREBROSIDASE DEFICIENCY|GALC Deficiencies|Globoid Cell Leukodystrophy|Leukoencephalopathies, Globoid Cell|Galactosylceramidase Deficiency Disease|GCL|Diffuse globoid body sclerosis|GALACTOSYL CERAMIDE LIPIDOSIS|Deficiency Disease, Galactosylceramide-beta-Galactosidase|Krabbe's leukodystrophy|Diseases, Galactosylceramide-beta-Galactosidase Deficiency|Galactosylceramide beta-galactosidase deficiency|Deficiencies, Galactocerebrosidase|Leukodystrophies, Globoid|Diffuse globoid cell cerebral sclerosis|Deficiency Diseases, Galactosylceramidase|Globoid Leukodystrophy|beta-Galactosidase Deficiency, Galactosylceramide|GLOBOID CELL LEUKOENCEPHALOPATHY|Galactosylceramide Beta-Galactosidase Deficiency|Disease, Galactosylceramidase Deficiency|Cell Leukodystrophy, Globoid|Krabbe Leukodystrophy|Galactosylceramide-beta-Galactosidase Deficiency Diseases|BRAIN, SCLEROSIS, GLOBOID CELL|krabbe's leukodystrophy|Deficiency, GALC|Galactocerebroside beta-galactosidase deficiency|Krabbe leucodystrophy|Deficiency Diseases, Galactosylceramide-beta-Galactosidase|Leukodystrophy, globoid cell|Globoid Cell Leukoencephalopathy|Globoid Body Sclerosis, Diffuse|Leukodystrophy, Globoid cell|KRABBE DISEASE|Krabbes Disease|galactosylceramide lipidosis|Galactosylceramide-beta-Galactosidase Deficiency Disease|beta galactocerebrosidase deficiency|Globoid leukodystrophy|Galactosylceramide beta Galactosidase Deficiency|krabbe's disease|GALC DEFICIENCY|krabbe disease|Globoid Cell Leukodystrophies|Galactosylceramide beta-Galactosidase Deficiencies|Leukoencephalopathy, Globoid Cell|Cell Leukoencephalopathy, Globoid|Globoid Leukodystrophies|globoid cell leukodystrophy|Cell Leukoencephalopathies, Globoid|LEUKODYSTROPHY, GLOBOID CELL|disease krabbes|Leukodystrophy, Krabbe's|Deficiency, Galactocerebrosidase|krabbes disease|GALC Deficiency|Krabbe's disease|Krabbe's Leukodystrophy|Deficiency, Galactosylceramide beta-Galactosidase|Galactosylsphingosine Lipidosis|Cell Leukodystrophies, Globoid|Globoid cell leucodystrophy|Galactosylceramide lipidosis|Galactosylceramide beta-galactosidase deficiency (disorder)|leukodystrophy krabbe|Deficiencies, GALC|disease krabbe|GCL - Globoid cell leucodystrophy|GALACTOSYLCERAMIDE BETA-GALACTOSIDASE DEFICIENCY|Galactosylceramidase Deficiency Diseases|Disease, Galactosylceramide-beta-Galactosidase Deficiency|Deficiencies, Galactosylceramide beta-Galactosidase|Krabbe's Disease|Leukodystrophy, Krabbe|Krabbe disease | Globoid cell leukodystrophy |
C0166415 | A nuclear transcription factor. Heterodimerization with RETINOID X RECEPTOR GAMMA is important to metabolism of LIPIDS. It is the target of FIBRATES to control HYPERLIPIDEMIAS. | PPAR alpha|PPARalpha|Peroxisome Proliferator-Activated Receptor alpha|Peroxisome Proliferator Activated Receptor alpha | PPAR alpha |
C0033954 | An intermediate in the biosynthesis of cerebrosides. It is formed by reaction of sphingosine with UDP-galactose and then itself reacts with fatty acid-Coenzyme A to form the cerebroside. | Psychosine|Galactoside, Sphingosine|Galactosylsphingosine|beta-D-Galactopyranoside, 2-amino-3-hydroxy-4-octadecenyl, (R-(R*,S*-(E)))-|Sphingosine Galactoside | Psychosine |
C0165465 | null | RS-15385-197 | RS 15385-197 |
C0165465 | null | RS-15385-197 | RS 15385-197 |
C0521450 | null | Lysosomal | lysosomal |
C0277785 | Deranged function in an individual or an organ that is due to a disease. (MedicineNet.com) | Functional disorder|Functional disorder, NOS|Dysfunction, NOS|Pathophysiology|Functional disorder (disorder)|Functional disturbance, NOS|Malfunction, NOS|functional disorders|dysfunction|pathophysiology|Dysfunction|functional disturbance|Functional disturbance|Physiopathology | Functional disorder |
C0077503 | Cell surface receptors that bind TUMOR NECROSIS FACTORS and trigger changes which influence the behavior of cells. | Tumor Necrosis Factor Receptor Family|tnf receptor|Cachectin Receptors|TNF Receptors|TNFRSF Protein|Receptors, TNF|Tumor necrosis factor--Receptors|TNFR|Receptors, Tumor Necrosis Factor|Receptors, Cachectin|Tumor Necrosis Factor Receptor|tumor necrosis factor receptor|TNF Receptor Superfamily|TNF Receptor Family Protein|receptors tnf|Tumor Necrosis Factor Receptors|tumor necrosis factor receptors|Tumor Necrosis Factor Receptor Superfamily|TNF Receptor|Receptor, TNF | Tumor Necrosis Factor Receptor |
C1451398 | null | null | luciferase, Photinus |
C1451398 | null | null | luciferase, Photinus |
C0024296 | Specialized tissues that are components of the lymphatic system. They provide fixed locations within the body where a variety of LYMPHOCYTES can form, mature and multiply. The lymphoid tissues are connected by a network of LYMPHATIC VESSELS. | Lymphatic tissue|Lymphocytic tissue|Tissues, Lymphatic|tissue lymphoid|Lymphatic Tissues|Lymphatic tissue (body structure)|Lymphoid Tissue|Lymphocytic tissue structure|Lymphatic Tissue|lymphatic tissues|lymphoid tissues|lymphatic tissue|Lymphocytic tissue structure (body structure)|Tissue, Lymphatic|Lymphoid Tissues|Lymphoid tissue|Tissue, Lymphoid|Tissues, Lymphoid|lymphoid tissue|lymphatic organs | Lymphoid Tissue |
C0020179 | A familial disorder inherited as an autosomal dominant trait and characterized by the onset of progressive CHOREA and DEMENTIA in the fourth or fifth decade of life. Common initial manifestations include paranoia; poor impulse control; DEPRESSION; HALLUCINATIONS; and DELUSIONS. Eventually intellectual impairment; loss of fine motor control; ATHETOSIS; and diffuse chorea involving axial and limb musculature develops, leading to a vegetative state within 10-15 years of disease onset. The juvenile variant has a more fulminant course including SEIZURES; ATAXIA; dementia; and chorea. (From Adams et al., Principles of Neurology, 6th ed, pp1060-4) | HC - Huntington chorea|Chorea, Chronic Progressive Hereditary (Huntington)|Huntington's chorea|HUNTINGTON CHOREA|Huntington's disease|HD - Huntington chorea|Huntington Chorea|huntington's chorea|Huntington disease|Huntington's Chorea|HD|huntingtons disease|Huntington's Disease|Progressive Chorea, Hereditary, Chronic (Huntington)|HUNTINGTON DISEASE|huntington chorea|Chronic progressive hereditary chorea|huntington's disease|Huntington Disease|Huntington Chronic Progressive Hereditary Chorea|Progressive Chorea, Chronic Hereditary (Huntington)|Huntington chorea|Huntington's chorea (disorder)|Chorea, Huntington's|CHOREA, CHRONIC PROGRESSIVE HEREDITARY|huntingtons chorea|Chorea, Huntington|Chronic progressive chorea|Chronic Progressive Hereditary Chorea (Huntington) | Huntington Disease |
C0003064 | Animals used or intended for use in research, testing, or teaching. | Laboratory animal|Laboratory animal (organism)|experimental animal|Laboratory Animal|animals experimental|Laboratory Animals|Laboratory animals|animal laboratory|animals laboratory|animal laboratories|laboratory animals|Animal, Laboratory|Animal, laboratory | Animals, Laboratory |
C0162512 | The phylogenetically newer part of the CORPUS STRIATUM consisting of the CAUDATE NUCLEUS and PUTAMEN. It is often called simply the striatum. | caudate putamen|Neostriatum|Striatum|neostriatum|striatum | Neostriatum |
C0013081 | A negative regulatory effect on physiological processes at the molecular, cellular, or systemic level. At the molecular level, the major regulatory sites include membrane receptors, genes (GENE EXPRESSION REGULATION), mRNAs (RNA, MESSENGER), and proteins. | Downregulation|Down-regulation|Down-regulation, function (observable entity)|downregulation|Down-Regulation (Physiology)|Down-regulation, function|Down Regulation|down-regulation|down regulation | Down-Regulation |
C1160185 | The transfer of genetic information to a bacterium from a bacteriophage or between bacterial or yeast cells mediated by a phage vector. [ISBN:0198506732] | transduction|Transduction | Viral Transduction |
C0678941 | A variation in the nucleic acid sequence of a specific gene. | Gene Variant|mutant gene|gene mutants|Gene Mutation|genes mutant|gene mutant|Gene Mutant | Gene Mutant |
C0035696 | RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. | messenger RNA|mrna|messenger ribonucleic acid|mRNA|Messenger ribonucleic acid (substance)|Messenger ribonucleic acid|messenger rna|RNA, messenger (mRNA)|Messenger RNA|messenger RNA (mRNA) | RNA, Messenger |
C0044507 | null | 1-nitropropane (substance)|1-Nitropropane|1-nitropropane | 1-nitropropane |
C0044507 | null | 1-nitropropane (substance)|1-Nitropropane|1-nitropropane | 1-nitropropane |
C0036723 | A PYRIDOXAL-phosphate containing enzyme that catalyzes the dehydration and deamination of L-serine to form pyruvate. This enzyme was formerly listed as EC 4.2.1.13. | L-serine ammonia-lyase (substance)|L-Serine Ammonia-Lyase|serine dehydratase|Dehydratase, L-Serine|Serine Deaminase|Deaminase, Serine|Ammonia-Lyase, L-Serine|Serine dehydratase|L-Serine dehydratase|L-hydroxyaminoacid dehydratase|Serine Dehydratase|L Serine Ammonia Lyase|Dehydratase, Serine-Threonine|L Serine Dehydratase|L-Serine Dehydratase|L-serine ammonia-lyase|Serine Threonine Dehydratase|Dehydratase, Serine|Serine deaminase|L-serine deaminase|Serine-Threonine Dehydratase|L-Serine hydro-lyase (deaminating)|L-Hydroxyaminoacid dehydratase|L-serine dehydratase | L-Serine Dehydratase |
C0036723 | A PYRIDOXAL-phosphate containing enzyme that catalyzes the dehydration and deamination of L-serine to form pyruvate. This enzyme was formerly listed as EC 4.2.1.13. | L-serine ammonia-lyase (substance)|L-Serine Ammonia-Lyase|serine dehydratase|Dehydratase, L-Serine|Serine Deaminase|Deaminase, Serine|Ammonia-Lyase, L-Serine|Serine dehydratase|L-Serine dehydratase|L-hydroxyaminoacid dehydratase|Serine Dehydratase|L Serine Ammonia Lyase|Dehydratase, Serine-Threonine|L Serine Dehydratase|L-Serine Dehydratase|L-serine ammonia-lyase|Serine Threonine Dehydratase|Dehydratase, Serine|Serine deaminase|L-serine deaminase|Serine-Threonine Dehydratase|L-Serine hydro-lyase (deaminating)|L-Hydroxyaminoacid dehydratase|L-serine dehydratase | L-Serine Dehydratase |
C0596988 | An altered form of an individual, organism, population, or genetic character that differs from the corresponding wild type due to one or more alterations (mutations). | mutants|mutant | Mutant |
C0682523 | null | cell human lines|human cell line|cell humans lines | Human Cell Line |
C0000618 | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | Mercaptopurinum|6-mp|Mercaptopurine-containing product|3H-Purine-6-thiol|6H-purine-6-thione, 1,7-dihydro- (9CI)|mercaptopurine|6 thiopurine|6 MP|6H-Purine-6-thione, 1,7-dihydro-|6H-Purine-6-thione, 1,7-dihydro- (9CI)|Mercapto-6-purine|6-thiopurine|1,7-Dihydro-6H-purine-6-thione|7-mercapto-1,3,4,6-tetrazaindene|7-Mercapto-1,3,4,6-tetrazaindene|6-Mercaptopurine|6-Purinethiol|6-purinethiol|Mercaptopurine|6-thioxopurine|3H purine-6-thiol|6-Thiopurine|MP|Purine-6-thiol (8CI)|6 Thiopurine|purine-6-thiol (8CI)|6-Thiohypoxanthine|6 Thiohypoxanthine|6 thiohypoxanthine|Mercaptopurine (substance)|Product containing mercaptopurine (medicinal product)|6 mercaptopurine|MERCAPTOPURINE|Mercapurin|Purine, 6-mercapto-|6-MP|Mern|Mercaptopurina|6-Thioxopurine|6-mercaptopurine|6MP|6 Mercaptopurine | mercaptopurine |
C0039902 | An antineoplastic compound which also has antimetabolite action. The drug is used in the therapy of acute leukemia. | 6-mercapto-2-aminopurine|2-amino 6MP|Tioguanine-containing product|2-Aminopurine-6(1H)-thione|Tioguanina|tioguanin|2-Aminopurine-6-thiol|2-aminopurin-6-thiol|thioguanine|Tioguanine|6-thioguanine|2 Amino 6 Purinethiol|2-aminopurine-6-thiol|Thioguanine|TG|6 Thioguanine|6H-Purine-6-thione, 2-amino-1,7-dihydro- (9CI)|2-amino-1,9-dihydropurine-6-thione|2-amino-6-mercaptopurine|6-mercaptoguanine|2-aminopurine-6(1H)-thione|2-Amino-6-merkaptopurin|Product containing tioguanine (medicinal product)|2-Aminopurin-6-thiol|2-Amino-6-mercaptopurine|ThG|6H-Purine-6-thione, 2-amino-1,7-dihydro-|2-amino-1,7-dihydro-6H-purine-6-thione|6-Amino-2-mercaptopurine|THIOGUANINE|Tioguanine (substance)|2-amino-6-purinethiol|2-Amino-1,7-dihydro-6H-purine-6-thione|tioguanine|Thioguanine Hydrate|6-TG|2-Amino 6MP|Tioguanin|6 mercaptoguanine|6-Mercapto-2-aminopurine|6-Thioguanine|6 Mercaptoguanine|2-Amino-6-purinethiol|6H-purine-6-thione, 2-amino-1,7-dihydro- (9CI)|2-Mercapto-6-aminopurine|Tioguaninum|6-Mercaptoguanine|2-Amino-6-Purinethiol|6 thioguanine|2-Aminopurine-6-thiol Hemihydrate|Thioguanine-containing product | thioguanine |
C0669846 | Equilibrative nucleoside transporter 2 (456 aa, ~50 kDa) is encoded by the human SLC29A2 gene. This protein plays a role in nucleoside transport for nucleotide salvage. | SLC29A2|Equilibrative, Nitrobenzylmercaptopurine Riboside (NBMPR)-Insensitive Nucleoside Transporter|Nucleoside Transporter, Ei-Type|Nitrobenzylmercaptopurine Riboside (NBMPR)-Insensitive, Equilibrative Nucleoside Transporter|Equilibrative Nucleoside Transporter 2|Hydrophobic Nucleolar Protein, 36 kDa|Solute Carrier Family 29 Member 2|Equilibrative Nitrobenzylmercaptopurine Riboside-Insensitive Nucleoside Transporter|Equilibrative NBMPR-Insensitive Nucleoside Transporter|Equilibrative-Nucleoside Transporter 2|SLC29A2 Protein|Solute Carrier-Family 29 (Nucleoside Transporters), Member 2|Delayed-Early Response Protein 12|36 kDa Nucleolar Protein HNP36 | Equilibrative-Nucleoside Transporter 2 |
C1517806 | Malignant hematopoietic cell originating in the clonal proliferation of myeloid or lymphoid precursor that undergoes an aberrant and poorly regulated process of organogenesis resulted in arrested maturation and cell capacity for unlimited self-renewal. | Leukemic Cell | Leukemic Cell |
C0597573 | null | thiopurine|thiopurines | thiopurine |
C0014834 | A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. | E coli|escherichia coli|ESCHERICHIA COLI|Escherichia Coli|Escherichia coli|Bacterium coli commune|e coli|Escherichia coli (organism)|Escherichia/Shigella coli|Bacterium coli|Bacillus coli|escherichia coli (E coli)|EC - Escherichia coli|Enterococcus coli|E. coli|E.COLI|escherichia coli (E coli) bacteria | Escherichia coli |
C1305923 | <p><b>Description:</b>A polypeptide resulting from the translation of a gene.</p> | polypeptide|Polypeptide, NOS|ActClassPolypeptide|Polypeptide|polypeptides|Product containing polypeptide (product)|Polypeptide-containing product|Polypeptide (substance) | Polypeptides |
C0014597 | Cells that line the inner and outer surfaces of the body by forming cellular layers (EPITHELIUM) or masses. Epithelial cells lining the SKIN; the MOUTH; the NOSE; and the ANAL CANAL derive from ectoderm; those lining the RESPIRATORY SYSTEM and the DIGESTIVE SYSTEM derive from endoderm; others (CARDIOVASCULAR SYSTEM and LYMPHATIC SYSTEM) derive from mesoderm. Epithelial cells can be classified mainly by cell shape and function into squamous, glandular and transitional epithelial cells. | Epithelial cell|Cells, Epithelial|Epitheliocyte|Epithelial cell, NOS|cell epithelial|epithelial cell|Cell, Epithelial|cells epithelial|Epithelial cell (cell)|Epithelial cells|Epithelial Cells|epithelial cells|EPITHELIAL CELL|Epithelial Cell | Epithelial Cells |
C0030956 | Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are linear polypeptides that are normally synthesized on RIBOSOMES. | Peptide|Peptide, NOS|peptides|Product containing peptide (product)|Peptide-containing product|Peptide (substance)|Peptides|peptide | Peptides |
C0025234 | Basic polypeptide from the venom of the honey bee (Apis mellifera). It contains 26 amino acids, has cytolytic properties, causes contracture of muscle, releases histamine, and disrupts surface tension, probably due to lysis of cell and mitochondrial membranes. | Melittin (honeybee)|mellitin|melittin|Mellitin|Melittin | Melitten |
C0597875 | A class of antimicrobial peptides discovered in the skin of XENOPUS LAEVIS. They kill bacteria by permeabilizing cell membranes without exhibiting significant toxicity against mammalian cells. | magainin|magainins | Magainins |